Philip R. Mayer

Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4

S. Ball, JoAnn Scatina, John Y. Kao et al. · Clinical Pharmacology & Therapeutics · 1999 · 233 citations

Unaltered Etanercept Pharmacokinetics With Concurrent Methotrexate in Patients With Rheumatoid Arthritis

Honghui Zhou, Philip R. Mayer, Joseph Wajdula et al. · The Journal of Clinical Pharmacology · 2004 · 62 citations

Pharmacokinetics of Gemtuzumab Ozogamicin as a Single‐Agent Treatment of Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

Mary Buckwalter, James A. Dowell, Joan Korth‐Bradley et al. · The Journal of Clinical Pharmacology · 2004 · 62 citations

Hematological Malignancy, Medicinal Chemistry, Gemtuzumab Ozogamicin +12

TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol

David F. Archer, Ginger D. Constantine, James A. Simon et al. · Menopause The Journal of The North American Menopause Society · 2016 · 42 citations · Full text

Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin

Joan Korth‐Bradley, Virginia Parks, Alain Patat et al. · Clinical Pharmacology in Drug Development · 2012 · 40 citations

Pharmaceutical Science, Antiparasitic Agent, Pharmacotherapy +18